GRB7 and breast cancer: Moreover, GRB7 expression has also been found to be a significant predictive factor to drug response and recurrence after cancer treatment, as it is exemplified in patients with operable TNBC where high GRB7 RNA and protein expression levels were associated with an elevated risk of recurrence in patients with breast cancer [13, 14].